I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Haberer, Lynda J.
11
results:
Search for persons
X
Format
Online (11)
Mediatypes
Articles (Online) (9)
OpenAccess-fulltext (2)
Sorted by: Relevance
Sorted by: Year
?
1
Integration of modeling and simulation to support changes t..:
Zuo, Peiying
;
Haberer, Lynda J.
;
Fang, Lei
...
The Journal of Clinical Pharmacology. 54 (2014) 11 - p. 1221-1229 , 2014
Link:
https://doi.org/10.1002/..
?
2
Single‐Dose Pharmacokinetics of the CCR9 Receptor Antagonis..:
Haberer, Lynda J.
;
Hacquoil, Kimberley
;
Ino, Hiroko
...
Clinical Pharmacology in Drug Development. 2 (2013) 4 - p. 387-393 , 2013
Link:
https://doi.org/10.1002/..
?
3
Effects of vercirnon on the activity of CYP3A4, CYP2C19 and..:
Haberer, Lynda J.
;
McSherry, Iain
;
Cargill, Anna
.
European Journal of Clinical Pharmacology. 70 (2013) 1 - p. 37-45 , 2013
Link:
https://doi.org/10.1007/..
?
4
Distinct Pharmacokinetic Profile and Safety of a Fixed‐Dose..:
Haberer, Lynda J.
;
Walls, Christine M.
;
Lener, Shelly E.
..
Headache: The Journal of Head and Face Pain. 50 (2010) 3 - p. 357-373 , 2010
Link:
https://doi.org/10.1111/..
?
5
Population pharmacokinetics of intravenous ondansetron in o..:
Mondick, John T.
;
Johnson, Brendan M.
;
Haberer, Lynda J.
...
European Journal of Clinical Pharmacology. 66 (2009) 1 - p. 77-86 , 2009
Link:
https://doi.org/10.1007/..
?
6
The Effect of 5α-Reductase Inhibition with Dutasteride and ..:
Amory, John K.
;
Wang, Christina
;
Swerdloff, Ronald S.
...
The Journal of Clinical Endocrinology & Metabolism. 92 (2007) 5 - p. 1659-1665 , 2007
Link:
https://doi.org/10.1210/..
?
7
Pharmacokinetics of Intravenous Ondansetron Hydrochloride i..:
Roth, Andrew G.
;
Cohen, Ira T.
;
Coté, Charles J.
..
Anesthesiology. 96 (2002) Sup 2 - p. A1267 , 2002
Link:
https://doi.org/10.1097/..
?
8
Central nervous system uptake kinetics of pentylenetetrazol..:
Haberer, Lynda J.
;
Pollack, Gary M.
Biopharmaceutics & Drug Disposition. 12 (1991) 1 - p. 59-71 , 1991
Link:
https://doi.org/10.1002/..
?
9
Emerging evidence from a systematic review of safety of pre..:
Joseph Davey, Dvora L
;
Pintye, Jillian
;
Baeten, Jared M
...
Journal of the International AIDS Society. 23 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1002/..
?
10
Defining gaps in pre-exposure prophylaxis delivery for preg..:
Pintye, Jillian
;
Davey, Dvora L Joseph
;
Wagner, Anjuli D
...
qt284327hm. , 2020
Link:
https://escholarship.org..
?
11
Emerging evidence from a systematic review of safety of pre..:
Davey, Dvora L Joseph
;
Pintye, Jillian
;
Baeten, Jared M
...
qt6sx4j05d. , 2020
Link:
https://escholarship.org..
1-11